Article Contents
- 2023 (Vol.86)
- 2022 (Vol.85)
- 2021 (Vol.84)
- 2020 (Vol.83)
- 2019 (Vol.82)
- 2018 (Vol.81)
- 2017 (Vol.80)
- 2016 (Vol.79)
- 2015 (Vol.78)
- 2014 (Vol.76)
- 2013 (Vol.74)
- 2012 (Vol.72)
- 2011 (Vol.70)
- 2010 (Vol.68)
- 2009 (Vol.66)
- 2008 (Vol.64)
- 2007 (Vol.62)
- 2006 (Vol.60)
- 2005 (Vol.58)
- 2004 (Vol.56)
- 2003 (Vol.54)
- 2002 (Vol.52)
Effect of Chlorhexidine Mouthrinse on Prevention of Microbial Contamination during EBUS-TBNA: A Study Protocol for a Randomized Controlled Trial
Park Jae Hyeon (Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.)
Park Jimyung (Seoul National University Hospital)
Kwak Nakwon (Seoul National University Hospital)
Choi Sun Mi (Seoul National University Hospital)
Park Young Sik (Seoul National University Hospital)
Lee Chang-Hoon (Seoul National University Hospital)
- Downloaded
- Viewed
Abstract
Background: Endobronchial ultrasound‒guided transbronchial needle aspiration (EBUS-TBNA) is a standard diagnostic method for mediastinal and hilar lymphadenopathy. Although rare, fatal infectious complications can occur following EBUS-TBNA. However, to date, there is a lack of effective preventive strategies to reduce these complications. We started a trial to investigate the effect of chlorhexidine mouthrinse on the prevention of microbial contamination during EBUS-TBNA.Methods: This study is a single-center, parallel-group, assessor-blinded randomized controlled trial (RCT). We will enroll 112 adult participants undergoing EBUS-TBNA using a convex probe, and randomly assign them to two groups at a 1:1 ratio. The intervention group will gargle for 1 minute with 100 mL of 0.12% chlorhexidine gluconate before EBUS-TBNA, while the control group will have no mouthrinse before the procedure. Immediately after completion of EBUS-TBNA on all targeted lesions with an aspiration needle, a needle wash sample will be taken by instilling 5 mL of sterile saline into the used needle. The primary outcome is colony forming unit (CFU) counts in aerobic cultures of the needle wash samples. Secondary outcomes are CFU counts in anaerobic cultures, fever within 24 hours after EBUS-TBNA, and infectious complications within 4 weeks after EBUS-TBNA.Conclusion: This trial was designed as the first RCT to investigate the effect of chlorhexidine mouthrinse on the prevention of microbial contamination during EBUS-TBNA. Results from this trial can provide clinical evidence for a simple, safe, and cost-effective strategy to prevent infectious complications following EBUS-TBNA (ClinicalTrials.gov ID: NCT04718922, registered on 22 January 2021).
- keywords
- EBUS-TBNA, Infectious Complication, Chlorhexidine Gluconate, Mouthrinse
Reference
1. Vaidya PJ, Munavvar M, Leuppi JD, Mehta AC, Chhajed PN. Endobronchial ultrasound-guided transbronchial needle aspiration:safe as it sounds. Respirology 2017;22:1093-101.
2. Gu P, Zhao YZ, Jiang LY, Zhang W, Xin Y, Han BH. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer 2009;45:1389-96.
3. Asano F, Aoe M, Ohsaki Y, Okada Y, Sasada S, Sato S, et al. Complications associated with endobronchial ultrasoundguided transbronchial needle aspiration: a nationwide survey by the Japan Society for Respiratory Endoscopy. Respir Res 2013;14:50.
4. Fukunaga K, Kawashima S, Seto R, Nakagawa H, Yamaguchi M, Nakano Y. Mediastinitis and pericarditis after endobronchial ultrasound-guided transbronchial needle aspiration. Respirol Case Rep 2015;3:16-8.
5. McGovern Murphy F, Grondin-Beaudoin B, Poulin Y, Boileau R, Dumoulin E. Mediastinal abscess following endobronchial ultrasound transbronchial needle aspiration in a patient with sarcoidosis. J Bronchology Interv Pulmonol 2015;22:370-2.
6. Matsuoka K, Ito A, Murata Y, Sakane T, Watanabe R, Imanishi N, et al. Severe mediastinitis and pericarditis after transbronchial needle aspiration. Ann Thorac Surg 2015;100:1881-3.
7. Voldby N, Folkersen BH, Rasmussen TR. Mediastinitis: a serious complication of endobronchial ultrasound-guided transbronchial needle aspiration. J Bronchology Interv Pulmonol 2017;24:75-9.
8. Lee HY, Kim J, Jo YS, Park YS. Bacterial pericarditis as a fatal complication after endobronchial ultrasound-guided transbronchial needle aspiration. Eur J Cardiothorac Surg 2015;48:630-2.
9. Epstein SK, Winslow CJ, Brecher SM, Faling LJ. Polymicrobial bacterial pericarditis after transbronchial needle aspiration:case report with an investigation on the risk of bacterial contamination during fiberoptic bronchoscopy. Am Rev Respir Dis 1992;146:523-5.
10. Minami D, Takigawa N, Oki M, Saka H, Shibayama T, Kiura K. Needle wash solution cultures following EBUS-TBNA with or without endobronchial intubation. Respir Investig 2018;56:356-60.
11. Shimada S, Furusawa H, Ishikawa T, Kamakura E, Suzuki T, Watanabe Y, et al. Development of mediastinal adenitis six weeks after endobronchial ultrasound-guided transbronchial needle aspiration. Respir Med Case Rep 2018;25:161-4.
12. Jones CG. Chlorhexidine: is it still the gold standard? Periodontol 2000 1997;15:55-62.
13. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration:guidance for protocols of clinical trials. BMJ 2013;346:e7586.
14. Steinfort DP, Johnson DF, Irving LB. Incidence of bacteraemia following endobronchial ultrasound-guided transbronchial needle aspiration. Eur Respir J 2010;36:28-32.
15. Donatsky AM, Holzknecht BJ, Arpi M, Vilmann P, Meisner S, Jorgensen LN, et al. Oral chlorhexidine and microbial contamination during endoscopy: possible implications for transgastric surgery: a randomized, clinical trial. Surg Endosc 2013;27:1914-22.
16. Hua F, Xie H, Worthington HV, Furness S, Zhang Q, Li C. Oral hygiene care for critically ill patients to prevent ventilatorassociated pneumonia. Cochrane Database Syst Rev 2016;10:CD008367.
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations